CAPLIN POINT LABORATORIES
Back to Balance Sheet
|
CAPLIN POINT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.64 Cr | ₹0.71 Cr |
What is the latest Contingent Liabilities ratio of CAPLIN POINT LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹0.64 Cr |
| Mar2024 | ₹0.64 Cr |
| Mar2023 | ₹0.64 Cr |
| Mar2022 | ₹0.71 Cr |
How is Contingent Liabilities of CAPLIN POINT LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | 2,639.06 | |
| Mar2025 | ₹0.64 Cr | 0.00 | |
| Mar2024 | ₹0.64 Cr | 0.00 | |
| Mar2023 | ₹0.64 Cr | -9.86 | |
| Mar2022 | ₹0.71 Cr | - | |
Compare Contingent Liabilities of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹17,767.7 Cr | 2.4% | -15.3% | 18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 2.4% |
-15.3% |
18.6% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses